Immunological Disorders and Immunotherapy
Open Access
ISSN: 2593-8509
+44-77-2385-9429
ISSN: 2593-8509
+44-77-2385-9429
India
Dr. Geetha Swamiligiah is currently working as a team leader at ADBS, Bangalore, India to lead a team of research scientists in their day-to-day activities for generation of high quality patient specific Human Induced pluripotent stem cells(HiPSCS), culturing, expansion and differentiation into different lineages and to work with in a collaboration with different stake holders related to the program. Previously, she has been working in the Industrial field for 14 years at Thermo Fisher Scientific, European Business and Technology Center (EBTC), EU program managed EUCH, Brussels and Life Technologies(Invitrogen) at various capacities as Application Scientist, Sector specialist and Program manager espectively.
Conference Proceeding
An Integrative approach to study mental illness through the resources of patient ???specific Human Induced pluripotent stem cells(HiPSCs)
Author(s): Geetha M. Swamilingiah
Abstract:
The translational research opportunities of stem cell research and regenerative medicines involves sharing of ideas and working at an academic (basic research) and clinical researches as well as industry representatives, at an interdisciplinary level. It involves a whole lot on an international platform to learn about the innovative technologies and strategies being implemented to assess the role of induced pluripotent stem cells and embryonic stem cells in cell therapy and translational medicine. Stem cells provide an attractive, physiologically suitable cellular system for disease modeling and have the potential to play an important role in drug discovery and cell therapies. In my talk, I would like to share interdisplinary strategies that are being employed to assess the role of induced pluripotent stem cells especially in area of mental illnesses include wel.. View More»